Difference between revisions of "Uterine cervix"

Jump to navigation Jump to search
m (→‎See also: link to gyne cyto)
(format)
Line 1: Line 1:
The '''cervix''', or uterine cervix to be more precise, is the gateway to the uterine corpus.  It is not infrequently afflicted by cancer -- squamous cell carcinoma. Prior to routine pap tests it was a leading cause of cancer death in women in the Western world.
The '''cervix''', or uterine cervix to be more precise, is the gateway to the uterine corpus.  It is not infrequently afflicted by cancer -- squamous cell carcinoma. Prior to routine pap tests it was a leading cause of cancer death in women in the Western world.
Polyps associated with the cervix are discussed the ''[[cervical polyp]]'' article.
 
Polyps associated with the cervix are discussed the ''[[cervical polyp]]'' article. 
 
[[Cytopathology]] of the cervix is dealt with in the ''[[gynecologic cytopathology]]'' article.


==Introduction==
==Introduction==
Line 58: Line 61:
===Histologic changes in CIN I, CIN II and CIN III===
===Histologic changes in CIN I, CIN II and CIN III===
*CIN I = cytoplasmic halos (koilocytic atypia), atypical cells close to basement membrane only.
*CIN I = cytoplasmic halos (koilocytic atypia), atypical cells close to basement membrane only.
**3:1 enlargement of nucleus vs. normal<ref>[need ref]</ref>
**3:1 enlargement of nucleus vs. normal.<ref>[need ref]</ref>
**Binucleation may be seen (cytopathic effect of HPV)<ref>[need ref]</ref>
**Binucleation may be seen (cytopathic effect of HPV).<ref>[need ref]</ref>
*CIN II = increased nuclear-cytoplasmic ratio, loss of polarity, incr. mitoses, hyperchromasia.
*CIN II = increased nuclear-cytoplasmic ratio, loss of polarity, incr. mitoses, hyperchromasia.
**If there are large nuclei... you should seen 'em on low power, i.e. 25x.
**If there are large nuclei... you should seen 'em on low power, i.e. 25x.
Line 75: Line 78:
** If there is a mitosis in the middle third (of the epithelial layer) = at least CIN II.
** If there is a mitosis in the middle third (of the epithelial layer) = at least CIN II.
** If there is a mitosis in the outer third = CIN III.
** If there is a mitosis in the outer third = CIN III.
*Nucleoli are usually NOT present in CIN.<ref>STC. Jan 2009.</ref>
*Nucleoli are usually NOT present in CIN.<ref>STC. January 2009.</ref>
**Nucleoli are common in reactive changes.<ref>STC. Jan 2009.</ref>
**Nucleoli are common in reactive changes.<ref>STC. January 2009.</ref>


====Kiolocytes versus benign squamous====
====Kiolocytes versus benign squamous====
Line 92: Line 95:
==Cervix cancer grading==
==Cervix cancer grading==
#Well-differentiated (keratinizing).
#Well-differentiated (keratinizing).
#Moderately diff. (nonkeratinizing).
#Moderately differentiated (nonkeratinizing).
#Poorly differentiated.
#Poorly differentiated.
Ref.:<ref>{{Ref PBoD|1077}}</ref>
Ref.:<ref>{{Ref PBoD|1077}}</ref>
Line 103: Line 106:
*Long rete ridges.
*Long rete ridges.
*Numerous beeds/blobs of epithelial cells that seem unlikely to be rete ridges.
*Numerous beeds/blobs of epithelial cells that seem unlikely to be rete ridges.
*Desmoplastic stroma - increased cellularity, spindle cell morphology<ref>NEED REF.</ref>
*Desmoplastic stroma - increased cellularity, spindle cell morphology.


Pitfalls:
Pitfalls:
Line 116: Line 119:
* Uniform cell spacing, i.e. NO crowding.  
* Uniform cell spacing, i.e. NO crowding.  
* NEGATIVES:
* NEGATIVES:
** No mitoses (think cancer/CIN if you see 'em)
** No mitoses (think cancer/CIN if you see 'em).
** Usually no hyperchromatism (think cancer/CIN if you see it)
** Usually no hyperchromatism (think cancer/CIN if you see it).


Notes:
Notes:
Line 130: Line 133:
*AIS/adenocarcinoma arises can arise from the endocervical glands.
*AIS/adenocarcinoma arises can arise from the endocervical glands.


===AIS===
===Adenocarcinoma in situ (AIS)===
*Diagnosis of AIS dependent primarily on nuclear changes:<ref>need ref</ref>
*Diagnosis of AIS dependent primarily on nuclear changes:
**Nuclear crowding.
**Nuclear crowding.
**Nuclear hyperchromasia.
**Nuclear hyperchromasia.
Line 139: Line 142:
**Hyperchromasia.
**Hyperchromasia.


===Invasive===
===Invasive adenocarcinoma===
*Invasive adenocarcinoma
Features:
**May be difficult to be certain.
*Stromal changes - "[[desmoplastic stroma]]/[[desmoplastic reaction]]".
**Stromal changes - "[[desmoplastic stroma]]/[[desmoplastic reaction]]".
**Fibrosis/streaming cells.
***Fibrosis/streaming cells.
*Gland fusion.
**Gland fusion.
*Glands too deep -- very fuzzy criterion.
**Glands too deep -- very fuzzy criterion.


Notes:  
Notes:  
Line 151: Line 153:
*AIS may occur together with CIN.
*AIS may occur together with CIN.
**not infrequently they (AIS, CIN) occur together - both are due, indirectly, to HPV infection.
**not infrequently they (AIS, CIN) occur together - both are due, indirectly, to HPV infection.
*May be difficult to be certain of invasion.


===IHC===
===IHC===
Uterus vs. cervix:<ref>LAE 15 Jan 2009.</ref>
Uterus vs. cervix:<ref>LAE. 15 January 2009.</ref>
*Cervix (typically): CEA+, p16+.
*Cervix (typically): CEA+, p16+.
** ... and ER-, PR-, vimentin-.
** ... and ER-, PR-, vimentin-.
Line 168: Line 171:


===Clear cell carcinoma===
===Clear cell carcinoma===
Associated with ''diethylstilbestrol'' exposure ''in utero''.<ref name=pmid19857300>{{Cite journal  | last1 = van Dijck | first1 = JA. | last2 = Doorduijn | first2 = Y. | last3 = Bulten | first3 = JH. | last4 = Verloop | first4 = J. | last5 = Massuger | first5 = LF. | last6 = Kiemeney | first6 = BA. | title = [Vaginal and cervical cancer due to diethylstilbestrol (DES); end epidemic] | journal = Ned Tijdschr Geneeskd | volume = 153 | issue =  | pages = A366 | month =  | year = 2009 | doi =  | PMID = 19857300 }}
Associated with ''diethylstilbestrol'' exposure ''in utero''.<ref name=pmid19857300>{{Cite journal  | last1 = van Dijck | first1 = JA. | last2 = Doorduijn | first2 = Y. | last3 = Bulten | first3 = JH. | last4 = Verloop | first4 = J. | last5 = Massuger | first5 = LF. | last6 = Kiemeney | first6 = BA. | title = [Vaginal and cervical cancer due to diethylstilbestrol (DES); end epidemic] | journal = Ned Tijdschr Geneeskd | volume = 153 | issue =  | pages = A366 | month =  | year = 2009 | doi =  | PMID = 19857300 }}</ref>
</ref>


==See also==
==See also==